Photo by Innerbody Research As weve covered developments in the telehealth space over the last several years, weve noticed a trend in which companies services expand and contract, offering new treatments and products only to later remove them from their catalogs
Conclusion Cagrilintide is emerging as one of the most promising next-generation peptides for obesity management
(PubMed) Mills JL, Scott JM, Kirke PN, et al
Disclosures Chioma Uzoigwe is a full-time employee and shareholder of Novo Nordisk Inc
Originally developed for diabetes, it has been proven to aid in significant weight loss when used at the appropriate dosages
In a clinical trial of the Wegovy pill in people without diabetes, people taking a 25 mg dose lost about 6% of their body weight in three months